chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Formication, Injection site pruritus, Paraesthesia, Rash erythematous, Rash maculo-papular
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421186. A 28-year-old female patient, with a history of mild seasonal allergies, received the following vaccination on 05 April 2011: ACAM2000 (lot number VV04003A). The patient's concomitant medication was reported as PROMETRIUM. On 13 April 2011, the patient felt her "skin crawling" and itching over left upper arm at vaccination site extending from near shoulder to elbow. She discovered a rash forming. On 14 April 2011, she developed maculopapular lesions 28 cm by 25 cm, florid red, and non-pustular. The lesion itself was 1 cm by 1 cm (vaccinia site). On 15 April 2011, the patient was seen at the clinic for right cheek tingling and right side of mouth drooping (slight). She required an Emergency visit. The patient was treated with ibuprofen 400 (units not provided) every six hours, ZYRTEC every morning, and BENADRYL 50 milligrams at bedtime (HS). The patient was to return to the clinic on 18 April 2011 at 8:00 AM. The outcome was reported as recovered. Documents held by sender: None.
Age: 28.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Skin lesion, VIIth nerve paralysis
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421186. A 28-year-old female patient, with a history of mild seasonal allergies, received the following vaccination on 05 April 2011: ACAM2000 (lot number VV04003A). The patient's concomitant medication was reported as PROMETRIUM. On 13 April 2011, the patient felt her "skin crawling" and itching over left upper arm at vaccination site extending from near shoulder to elbow. She discovered a rash forming. On 14 April 2011, she developed maculopapular lesions 28 cm by 25 cm, florid red, and non-pustular. The lesion itself was 1 cm by 1 cm (vaccinia site). On 15 April 2011, the patient was seen at the clinic for right cheek tingling and right side of mouth drooping (slight). She required an Emergency visit. The patient was treated with ibuprofen 400 (units not provided) every six hours, ZYRTEC every morning, and BENADRYL 50 milligrams at bedtime (HS). The patient was to return to the clinic on 18 April 2011 at 8:00 AM. The outcome was reported as recovered. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, JEV1, ANTH, JEV1, SMALL
Symptoms: Dizziness, Injection site erythema, Injection site inflammation, Injection site papule, Swelling
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421294. A 26-year-old male patient received the following vaccinations on 07 April 2011: ACAM2000 (lot number VV04003e), IXIARO (lot number JEV09L36A), BIOTHRAX (lot number JEV273). On 16 April 2011, 11 days post-vaccination, the patient developed redness and inflammation around the smallpox injection site. He also complained of lightheadedness, and was hospitalized. As the overall swelling decreased, he developed multiple small papules in a 4x4 inch area. Outcome was reported as recovered. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, JEV1, ANTH, JEV1, SMALL
Symptoms: Dizziness, Injection site erythema, Injection site papule, Vaccination site inflammation, Vaccination site swelling
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421294. A 26-year-old male patient received the following vaccinations on 07 April 2011: ACAM2000 (lot number VV04003e), IXIARO (lot number JEV09L36A), BIOTHRAX (lot number JEV273). On 16 April 2011, 11 days post-vaccination, the patient developed redness and inflammation around the smallpox injection site. He also complained of lightheadedness, and was hospitalized. As the overall swelling decreased, he developed multiple small papules in a 4x4 inch area. Outcome was reported as recovered. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, JEV1, ANTH, JEV1, SMALL
Symptoms: Dizziness, Injection site erythema, Injection site inflammation, Rash papular
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421294. A 26-year-old male patient received the following vaccinations on 07 April 2011: ACAM2000 (lot number VV04003e), IXIARO (lot number JEV09L36A), BIOTHRAX (lot number JEV273). On 16 April 2011, 11 days post-vaccination, the patient developed redness and inflammation around the smallpox injection site. He also complained of lightheadedness, and was hospitalized. As the overall swelling decreased, he developed multiple small papules in a 4x4 inch area. Outcome was reported as recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood electrolytes normal, Blood glucose normal, Full blood count normal, Hypoaesthesia oral, Lip swelling
Clinical narrative: This case was received on 23 June via a third party query tool search on the VAERS database, under reference number 421608. A 33-year-old male patient received ACAM2000 (lot number not reported), on 09 April 2011. On 17 April 2011, 8 days post-vaccination, the patient developed swelling of the lips, hands and feet. He also complained of numbness and itching of the tongue, and a generalized urticarial, pruritic rash. He presented to the emergency department, where laboratory data was normal other than glucose (115 mg/dL). Treatment included BENADRYL and ATARAX, and symptoms resolved within 36 hours.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Oedema peripheral, Pruritus, Rash pruritic, Urticaria
Clinical narrative: This case was received on 23 June via a third party query tool search on the VAERS database, under reference number 421608. A 33-year-old male patient received ACAM2000 (lot number not reported), on 09 April 2011. On 17 April 2011, 8 days post-vaccination, the patient developed swelling of the lips, hands and feet. He also complained of numbness and itching of the tongue, and a generalized urticarial, pruritic rash. He presented to the emergency department, where laboratory data was normal other than glucose (115 mg/dL). Treatment included BENADRYL and ATARAX, and symptoms resolved within 36 hours.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood glucose increased, Hypoaesthesia oral, Laboratory test normal, Lip swelling, Oedema peripheral
Clinical narrative: This case was received on 23 June via a third party query tool search on the VAERS database, under reference number 421608. A 33-year-old male patient received ACAM2000 (lot number not reported), on 09 April 2011. On 17 April 2011, 8 days post-vaccination, the patient developed swelling of the lips, hands and feet. He also complained of numbness and itching of the tongue, and a generalized urticarial, pruritic rash. He presented to the emergency department, where laboratory data was normal other than glucose (115 mg/dL). Treatment included BENADRYL and ATARAX, and symptoms resolved within 36 hours.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Oral pruritus, Rash pruritic, Urticaria
Clinical narrative: This case was received on 23 June via a third party query tool search on the VAERS database, under reference number 421608. A 33-year-old male patient received ACAM2000 (lot number not reported), on 09 April 2011. On 17 April 2011, 8 days post-vaccination, the patient developed swelling of the lips, hands and feet. He also complained of numbness and itching of the tongue, and a generalized urticarial, pruritic rash. He presented to the emergency department, where laboratory data was normal other than glucose (115 mg/dL). Treatment included BENADRYL and ATARAX, and symptoms resolved within 36 hours.
Age: 20.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: CSF white blood cell count increased, Lymphocyte percentage increased, Meningitis aseptic
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421615. A 20-year-old female patient received the following vaccinations on 08 April 2011: ACAM2000 (lot number VV04-003A), and BIOTHRAX (FAV261). On 20 April 2011, 12 days post-vaccination, the patient was hospitalized with aseptic meningitis. Cerebrospinal fluid was tested and revealed WBC 37 with 88% lymphs. The patient had no relevant medical history and was not ill at the time of vaccination. Recovery was unknown. Documents held by sender: none.
Age: 20.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: CSF lymphocyte count increased, CSF white blood cell count increased, Meningitis aseptic
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421615. A 20-year-old female patient received the following vaccinations on 08 April 2011: ACAM2000 (lot number VV04-003A), and BIOTHRAX (FAV261). On 20 April 2011, 12 days post-vaccination, the patient was hospitalized with aseptic meningitis. Cerebrospinal fluid was tested and revealed WBC 37 with 88% lymphs. The patient had no relevant medical history and was not ill at the time of vaccination. Recovery was unknown. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Myocarditis, Troponin I increased
Clinical narrative: This study case was received from the investigator (MILVAX) trial on 18 April 2011. A 20-year-old male subject, with no significant medical history, developed non-specific myocarditis 29 days after receiving an injection of ACAM2000, lot number not provided, on 15 June 2010. On 28 June 2010 the subject had an abnormal troponin I blood test of 00.51 and an abnormal electrocardiogram (ECG). The subject was diagnosed with non-specific myocarditis on 14 July 2010. On 20 July 2010, the subject's echocardiogram was reported as normal. The outcome was not reported. Additional information will be requested from the investigator. Follow-up information was received on 23 June/2011 via a third party query tool search on the VAERS database. New information consisted of VAERS ID number 421644. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: None.
Age: 33.0
Sex: F
Vaccine: SMALL, SMALL, SMALL
Symptoms: Chest X-ray, Chest pain, Dyspnoea, Electrocardiogram, Heart rate increased
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421656. A 33-year-old female patient received ACAM2000 (lot number VV04-003A), on 21 April 2011. On 23 April 2011, 2 days post-vaccination, the patient developed bilateral chest pain accompanied by difficulty breathing and increased heart rate. She did not have an irregular heart beat, fever, chills, or night sweats. A chest x-ray and EKG were performed; results were not reported. At the time of the report, symptoms had neither increased nor decreased in severity. Outcome was reported as unknown.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blepharitis, Blister, Erythema, Erythema of eyelid, Papule
Clinical narrative: Initial case retrieved from the scientific literature on 25 April 2011. It pertains to 1 of 4 patients who experienced adverse events following exposure to a military service member who had recently received the ACAM2000 vaccine. The other 3 patients are captured in case numbers 2010-04089, 2010-04090, 2011-02468; the case for the military service member is captured in 2011-02465. Abstract: During February and March 2010, the State Department of Health investigated secondary and tertiary vaccinia contact transmission from a military vaccinee to 4 close contacts. Identification of these cases underscores the need for strict adherence to postvaccination infection control guidance to avoid transmission of the live virus. On 23 February 2010, a military service member received ACAM2000 (lot not reported) in preparation for deployment. On 27 February 2010 he wrestled 2 persons in a semi-professional wrestling match, during which the dressing covering the vaccination site was detached. One of the 2 persons was a 24-year-old male, with no underlying risk factors, who was exposed to the service member on 27 February 2010 during the wrestling match. On 01 March 2010 he developed lesions on his face, neck, chin, and left eye which were associated with substantial pruritis, exudate, and erythema. He was contacted by the state department of health on 11 March 2010, and notified of his exposure to the vaccinee. On 12 March 2010 he was evaluated by the public health physician, and at that time was noted to have numerous papular lesions that were umbilicated with overlying vesicles, several of which were draining serous fluid. He was also noted to have involvement of the left lower eyelid with substantial erythema and early blepharitis. Vaccinia virus (VAVC) was clinically diagnosed at that time. He subsequently received slit-lamp examination by a local ophthalmologist, who treated him with trifluidine ophthalmic solution. The blepharitis and eyelid erythema resolved within 48 hours of beginning treatment. The patient was followed until he had complete lesion resolution, approximately 3 weeks. Follow-up information was retrieved via a third-party query tool search of the VAERS database on 21 July 2011, and provided the VAERS number (422006). The following codes have been added: blister, erythema of eyelid, papule, secretion discharge and vaccinia virus infection. No new information was added to the case. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pruritus, Secondary transmission, Secretion discharge, Skin lesion, Slit-lamp examination
Clinical narrative: Initial case retrieved from the scientific literature on 25 April 2011. It pertains to 1 of 4 patients who experienced adverse events following exposure to a military service member who had recently received the ACAM2000 vaccine. The other 3 patients are captured in case numbers 2010-04089, 2010-04090, 2011-02468; the case for the military service member is captured in 2011-02465. Abstract: During February and March 2010, the State Department of Health investigated secondary and tertiary vaccinia contact transmission from a military vaccinee to 4 close contacts. Identification of these cases underscores the need for strict adherence to postvaccination infection control guidance to avoid transmission of the live virus. On 23 February 2010, a military service member received ACAM2000 (lot not reported) in preparation for deployment. On 27 February 2010 he wrestled 2 persons in a semi-professional wrestling match, during which the dressing covering the vaccination site was detached. One of the 2 persons was a 24-year-old male, with no underlying risk factors, who was exposed to the service member on 27 February 2010 during the wrestling match. On 01 March 2010 he developed lesions on his face, neck, chin, and left eye which were associated with substantial pruritis, exudate, and erythema. He was contacted by the state department of health on 11 March 2010, and notified of his exposure to the vaccinee. On 12 March 2010 he was evaluated by the public health physician, and at that time was noted to have numerous papular lesions that were umbilicated with overlying vesicles, several of which were draining serous fluid. He was also noted to have involvement of the left lower eyelid with substantial erythema and early blepharitis. Vaccinia virus (VAVC) was clinically diagnosed at that time. He subsequently received slit-lamp examination by a local ophthalmologist, who treated him with trifluidine ophthalmic solution. The blepharitis and eyelid erythema resolved within 48 hours of beginning treatment. The patient was followed until he had complete lesion resolution, approximately 3 weeks. Follow-up information was retrieved via a third-party query tool search of the VAERS database on 21 July 2011, and provided the VAERS number (422006). The following codes have been added: blister, erythema of eyelid, papule, secretion discharge and vaccinia virus infection. No new information was added to the case. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Vaccinia virus infection
Clinical narrative: Initial case retrieved from the scientific literature on 25 April 2011. It pertains to 1 of 4 patients who experienced adverse events following exposure to a military service member who had recently received the ACAM2000 vaccine. The other 3 patients are captured in case numbers 2010-04089, 2010-04090, 2011-02468; the case for the military service member is captured in 2011-02465. Abstract: During February and March 2010, the State Department of Health investigated secondary and tertiary vaccinia contact transmission from a military vaccinee to 4 close contacts. Identification of these cases underscores the need for strict adherence to postvaccination infection control guidance to avoid transmission of the live virus. On 23 February 2010, a military service member received ACAM2000 (lot not reported) in preparation for deployment. On 27 February 2010 he wrestled 2 persons in a semi-professional wrestling match, during which the dressing covering the vaccination site was detached. One of the 2 persons was a 24-year-old male, with no underlying risk factors, who was exposed to the service member on 27 February 2010 during the wrestling match. On 01 March 2010 he developed lesions on his face, neck, chin, and left eye which were associated with substantial pruritis, exudate, and erythema. He was contacted by the state department of health on 11 March 2010, and notified of his exposure to the vaccinee. On 12 March 2010 he was evaluated by the public health physician, and at that time was noted to have numerous papular lesions that were umbilicated with overlying vesicles, several of which were draining serous fluid. He was also noted to have involvement of the left lower eyelid with substantial erythema and early blepharitis. Vaccinia virus (VAVC) was clinically diagnosed at that time. He subsequently received slit-lamp examination by a local ophthalmologist, who treated him with trifluidine ophthalmic solution. The blepharitis and eyelid erythema resolved within 48 hours of beginning treatment. The patient was followed until he had complete lesion resolution, approximately 3 weeks. Follow-up information was retrieved via a third-party query tool search of the VAERS database on 21 July 2011, and provided the VAERS number (422006). The following codes have been added: blister, erythema of eyelid, papule, secretion discharge and vaccinia virus infection. No new information was added to the case. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blepharitis, Blister, Erythema, Erythema of eyelid, Exposure to vaccinated person
Clinical narrative: Initial case retrieved from the scientific literature on 25 April 2011. It pertains to 1 of 4 patients who experienced adverse events following exposure to a military service member who had recently received the ACAM2000 vaccine. The other 3 patients are captured in case numbers 2010-04089, 2010-04090, 2011-02468; the case for the military service member is captured in 2011-02465. Abstract: During February and March 2010, the State Department of Health investigated secondary and tertiary vaccinia contact transmission from a military vaccinee to 4 close contacts. Identification of these cases underscores the need for strict adherence to postvaccination infection control guidance to avoid transmission of the live virus. On 23 February 2010, a military service member received ACAM2000 (lot not reported) in preparation for deployment. On 27 February 2010 he wrestled 2 persons in a semi-professional wrestling match, during which the dressing covering the vaccination site was detached. One of the 2 persons was a 24-year-old male, with no underlying risk factors, who was exposed to the service member on 27 February 2010 during the wrestling match. On 01 March 2010 he developed lesions on his face, neck, chin, and left eye which were associated with substantial pruritis, exudate, and erythema. He was contacted by the state department of health on 11 March 2010, and notified of his exposure to the vaccinee. On 12 March 2010 he was evaluated by the public health physician, and at that time was noted to have numerous papular lesions that were umbilicated with overlying vesicles, several of which were draining serous fluid. He was also noted to have involvement of the left lower eyelid with substantial erythema and early blepharitis. Vaccinia virus (VAVC) was clinically diagnosed at that time. He subsequently received slit-lamp examination by a local ophthalmologist, who treated him with trifluidine ophthalmic solution. The blepharitis and eyelid erythema resolved within 48 hours of beginning treatment. The patient was followed until he had complete lesion resolution, approximately 3 weeks. Follow-up information was retrieved via a third-party query tool search of the VAERS database on 21 July 2011, and provided the VAERS number (422006). The following codes have been added: blister, erythema of eyelid, papule, secretion discharge and vaccinia virus infection. No new information was added to the case. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pruritus, Rash papular, Secondary transmission, Secretion discharge, Skin lesion
Clinical narrative: Initial case retrieved from the scientific literature on 25 April 2011. It pertains to 1 of 4 patients who experienced adverse events following exposure to a military service member who had recently received the ACAM2000 vaccine. The other 3 patients are captured in case numbers 2010-04089, 2010-04090, 2011-02468; the case for the military service member is captured in 2011-02465. Abstract: During February and March 2010, the State Department of Health investigated secondary and tertiary vaccinia contact transmission from a military vaccinee to 4 close contacts. Identification of these cases underscores the need for strict adherence to postvaccination infection control guidance to avoid transmission of the live virus. On 23 February 2010, a military service member received ACAM2000 (lot not reported) in preparation for deployment. On 27 February 2010 he wrestled 2 persons in a semi-professional wrestling match, during which the dressing covering the vaccination site was detached. One of the 2 persons was a 24-year-old male, with no underlying risk factors, who was exposed to the service member on 27 February 2010 during the wrestling match. On 01 March 2010 he developed lesions on his face, neck, chin, and left eye which were associated with substantial pruritis, exudate, and erythema. He was contacted by the state department of health on 11 March 2010, and notified of his exposure to the vaccinee. On 12 March 2010 he was evaluated by the public health physician, and at that time was noted to have numerous papular lesions that were umbilicated with overlying vesicles, several of which were draining serous fluid. He was also noted to have involvement of the left lower eyelid with substantial erythema and early blepharitis. Vaccinia virus (VAVC) was clinically diagnosed at that time. He subsequently received slit-lamp examination by a local ophthalmologist, who treated him with trifluidine ophthalmic solution. The blepharitis and eyelid erythema resolved within 48 hours of beginning treatment. The patient was followed until he had complete lesion resolution, approximately 3 weeks. Follow-up information was retrieved via a third-party query tool search of the VAERS database on 21 July 2011, and provided the VAERS number (422006). The following codes have been added: blister, erythema of eyelid, papule, secretion discharge and vaccinia virus infection. No new information was added to the case. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Slit-lamp examination, Vaccinia virus infection
Clinical narrative: Initial case retrieved from the scientific literature on 25 April 2011. It pertains to 1 of 4 patients who experienced adverse events following exposure to a military service member who had recently received the ACAM2000 vaccine. The other 3 patients are captured in case numbers 2010-04089, 2010-04090, 2011-02468; the case for the military service member is captured in 2011-02465. Abstract: During February and March 2010, the State Department of Health investigated secondary and tertiary vaccinia contact transmission from a military vaccinee to 4 close contacts. Identification of these cases underscores the need for strict adherence to postvaccination infection control guidance to avoid transmission of the live virus. On 23 February 2010, a military service member received ACAM2000 (lot not reported) in preparation for deployment. On 27 February 2010 he wrestled 2 persons in a semi-professional wrestling match, during which the dressing covering the vaccination site was detached. One of the 2 persons was a 24-year-old male, with no underlying risk factors, who was exposed to the service member on 27 February 2010 during the wrestling match. On 01 March 2010 he developed lesions on his face, neck, chin, and left eye which were associated with substantial pruritis, exudate, and erythema. He was contacted by the state department of health on 11 March 2010, and notified of his exposure to the vaccinee. On 12 March 2010 he was evaluated by the public health physician, and at that time was noted to have numerous papular lesions that were umbilicated with overlying vesicles, several of which were draining serous fluid. He was also noted to have involvement of the left lower eyelid with substantial erythema and early blepharitis. Vaccinia virus (VAVC) was clinically diagnosed at that time. He subsequently received slit-lamp examination by a local ophthalmologist, who treated him with trifluidine ophthalmic solution. The blepharitis and eyelid erythema resolved within 48 hours of beginning treatment. The patient was followed until he had complete lesion resolution, approximately 3 weeks. Follow-up information was retrieved via a third-party query tool search of the VAERS database on 21 July 2011, and provided the VAERS number (422006). The following codes have been added: blister, erythema of eyelid, papule, secretion discharge and vaccinia virus infection. No new information was added to the case. Documents held by sender: None.
Age: 44.0
Sex: M
Vaccine: ANTH, RAB, SMALL, ANTH, RAB, SMALL
Symptoms: Herpes simplex serology negative, Herpes zoster, Varicella virus test positive, Wound
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422053. A 44-year-old male patient received the following vaccinations on 15 April 2011: a left arm ACAM2000 (lot number VV04003A), a right arm injection (route unknown) of BIOTHRAX (EMERGENT, lot number FAV269), and a right arm intramuscular injection of RABIES VACCINE (manufacturer unknown, lot number 466011A). The patient had a history of headache (HA) and lumbar radiculopathy. The patient had no current illnesses and took no other medications. The patient developed a herpes zoster outbreak on lower left posterior leg after multiple vaccines which required an Emergency visit. The patient had a virology test on 27 April 2011 of the left leg wound which showed varicella zoster virus isolated and was simplex negative. The outcome was reported as not recovered. Documents held by sender: None.
Age: 44.0
Sex: M
Vaccine: ANTH, RAB, SMALL, ANTH, RAB, SMALL
Symptoms: Herpes zoster, Varicella virus test positive
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422053. A 44-year-old male patient received the following vaccinations on 15 April 2011: a left arm ACAM2000 (lot number VV04003A), a right arm injection (route unknown) of BIOTHRAX (EMERGENT, lot number FAV269), and a right arm intramuscular injection of RABIES VACCINE (manufacturer unknown, lot number 466011A). The patient had a history of headache (HA) and lumbar radiculopathy. The patient had no current illnesses and took no other medications. The patient developed a herpes zoster outbreak on lower left posterior leg after multiple vaccines which required an Emergency visit. The patient had a virology test on 27 April 2011 of the left leg wound which showed varicella zoster virus isolated and was simplex negative. The outcome was reported as not recovered. Documents held by sender: None.
Age: 44.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Atrial flutter, Cardiac ablation, Incision site pain, Palpitations
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422076. A 44-year-old male patient received the following vaccination on 01 April 2011: a left arm ACAM2000 (lot number VV04003). The patient did not drink alcohol and did not use tobacco. He has no current illnesses, no medical history and took no concomitant medications. The patient was seen in the Emergency Room (ER) for feeling palpitations and was diagnosed with Atrial Flutter. He was hospitalized on 23 April 2011 and underwent an ablation procedure. The patient's laboratory findings included blood pressure 98/65, heart rate 60, respiratory rate 15, temperature 97.2 degrees Fahrenheit, height 70 inches, weight 178 pounds, oxygen saturation (SpO2) 97%, Body mass index (BMI) 25.54, and body surface area (BSA) 1.986 square meters. The patient had bandages on both inguinal areas and had complained of pain at the incision site of 5 out of 10 moderate. He was attending sick call after the Atrial Flutter operation on 26 April 2011. He was released from the hospital on 27 April 2011. The patient was instructed to take oral (po) aspirin 325 milligrams daily and instruction to carry no more than 5 pounds for the next 5 days. He was to follow-up with a physician on 03 May 2011 at the hospital. The patient feels fine now. He had no bruises and no swelling "D/I/C". The outcome was reported as recovered. Documents held by sender: None.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest X-ray normal, Chest pain, Electrocardiogram normal, Headache, Pain in extremity
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422105. A 34-year-old male patient received ACAM2000 (lot number VV04003A) on 22 April 2011. On 01 May 2011, 9 days post-vaccination, the patient developed chest pain which radiated to the left arm, fever, and headache. The patient presented to the emergency department; troponin was negative, and EKG and chest x-ray were both normal. History was noted as "aspirin". Outcome was unknown.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pyrexia, Troponin
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422105. A 34-year-old male patient received ACAM2000 (lot number VV04003A) on 22 April 2011. On 01 May 2011, 9 days post-vaccination, the patient developed chest pain which radiated to the left arm, fever, and headache. The patient presented to the emergency department; troponin was negative, and EKG and chest x-ray were both normal. History was noted as "aspirin". Outcome was unknown.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest X-ray normal, Chest pain, Electrocardiogram normal, Headache, Pyrexia
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422105. A 34-year-old male patient received ACAM2000 (lot number VV04003A) on 22 April 2011. On 01 May 2011, 9 days post-vaccination, the patient developed chest pain which radiated to the left arm, fever, and headache. The patient presented to the emergency department; troponin was negative, and EKG and chest x-ray were both normal. History was noted as "aspirin". Outcome was unknown.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Troponin
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422105. A 34-year-old male patient received ACAM2000 (lot number VV04003A) on 22 April 2011. On 01 May 2011, 9 days post-vaccination, the patient developed chest pain which radiated to the left arm, fever, and headache. The patient presented to the emergency department; troponin was negative, and EKG and chest x-ray were both normal. History was noted as "aspirin". Outcome was unknown.
Age: 31.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Aggression, Erythema, Myalgia, Pyrexia, Rash
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search of the VAERS database, under reference number 422405. A 31-year-old male patient received ACAM2000 (lot number not reported) on 29 April 2011 and nine days later he developed an aggressive take with surrounding erythema approximately 10cm. He had a dozen (+) papules/pustules to chest/neck, a fever to 103.1 and myalgias. The event required an emergency room visit. Other medications, concurrent illnesses and history were reported as "none". Outcome was unknown. To be noted, MedDRA coding for "aggressive take" in this VAERS report had been coded as Aggression. This MedDRA coding has been amended to "Robust take following exposure to vaccinia virus". Documents held by sender: None.
Age: 31.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Rash papular, Rash pustular
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search of the VAERS database, under reference number 422405. A 31-year-old male patient received ACAM2000 (lot number not reported) on 29 April 2011 and nine days later he developed an aggressive take with surrounding erythema approximately 10cm. He had a dozen (+) papules/pustules to chest/neck, a fever to 103.1 and myalgias. The event required an emergency room visit. Other medications, concurrent illnesses and history were reported as "none". Outcome was unknown. To be noted, MedDRA coding for "aggressive take" in this VAERS report had been coded as Aggression. This MedDRA coding has been amended to "Robust take following exposure to vaccinia virus". Documents held by sender: None.
Age: 31.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Myalgia, Papule, Pyrexia, Rash pustular
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search of the VAERS database, under reference number 422405. A 31-year-old male patient received ACAM2000 (lot number not reported) on 29 April 2011 and nine days later he developed an aggressive take with surrounding erythema approximately 10cm. He had a dozen (+) papules/pustules to chest/neck, a fever to 103.1 and myalgias. The event required an emergency room visit. Other medications, concurrent illnesses and history were reported as "none". Outcome was unknown. To be noted, MedDRA coding for "aggressive take" in this VAERS report had been coded as Aggression. This MedDRA coding has been amended to "Robust take following exposure to vaccinia virus". Documents held by sender: None.
Age: 31.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Robust take following exposure to vaccinia virus
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search of the VAERS database, under reference number 422405. A 31-year-old male patient received ACAM2000 (lot number not reported) on 29 April 2011 and nine days later he developed an aggressive take with surrounding erythema approximately 10cm. He had a dozen (+) papules/pustules to chest/neck, a fever to 103.1 and myalgias. The event required an emergency room visit. Other medications, concurrent illnesses and history were reported as "none". Outcome was unknown. To be noted, MedDRA coding for "aggressive take" in this VAERS report had been coded as Aggression. This MedDRA coding has been amended to "Robust take following exposure to vaccinia virus". Documents held by sender: None.
Age: 35.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Anxiety, Axillary pain, Chest pain, Electrocardiogram normal, Generalised vaccinia
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422460. A 35 year-old male patient who had no current illness or history had received on 27 April 2011, a left arm injection of ACAM2000 (lot number VV04003A) and 11 days later on 08 May 2011, experienced blistering around smallpox site, armpit swelling and sore, tingling in left hand, multiple bumps on back of head, neck, both arms, chest, finger and back. He presented to the clinic with chest pain on 09 May 2011. An EKG was performed to rule out myocarditis/pericarditis and it did not show any signs of either condition. Treatments were not reported. According to the report, the chest pain may have due to anxiety related to the diagnosis of generalized vaccinia. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
Age: 35.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Injection site vesicles, Oedema peripheral, Paraesthesia, Rash
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422460. A 35 year-old male patient who had no current illness or history had received on 27 April 2011, a left arm injection of ACAM2000 (lot number VV04003A) and 11 days later on 08 May 2011, experienced blistering around smallpox site, armpit swelling and sore, tingling in left hand, multiple bumps on back of head, neck, both arms, chest, finger and back. He presented to the clinic with chest pain on 09 May 2011. An EKG was performed to rule out myocarditis/pericarditis and it did not show any signs of either condition. Treatments were not reported. According to the report, the chest pain may have due to anxiety related to the diagnosis of generalized vaccinia. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
Age: 35.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Activities of daily living impaired, Adverse reaction, Electrocardiogram normal, Pain in extremity, Rash
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422460. A 35 year-old male patient who had no current illness or history had received on 27 April 2011, a left arm injection of ACAM2000 (lot number VV04003A) and 11 days later on 08 May 2011, experienced blistering around smallpox site, armpit swelling and sore, tingling in left hand, multiple bumps on back of head, neck, both arms, chest, finger and back. He presented to the clinic with chest pain on 09 May 2011. An EKG was performed to rule out myocarditis/pericarditis and it did not show any signs of either condition. Treatments were not reported. According to the report, the chest pain may have due to anxiety related to the diagnosis of generalized vaccinia. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
Age: 35.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Injection site vesicles, Local swelling, Paraesthesia, Rash
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422460. A 35 year-old male patient who had no current illness or history had received on 27 April 2011, a left arm injection of ACAM2000 (lot number VV04003A) and 11 days later on 08 May 2011, experienced blistering around smallpox site, armpit swelling and sore, tingling in left hand, multiple bumps on back of head, neck, both arms, chest, finger and back. He presented to the clinic with chest pain on 09 May 2011. An EKG was performed to rule out myocarditis/pericarditis and it did not show any signs of either condition. Treatments were not reported. According to the report, the chest pain may have due to anxiety related to the diagnosis of generalized vaccinia. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
Age: 33.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Axillary pain, Injection site pain, Injection site swelling, Lymphadenopathy, Musculoskeletal chest pain
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422778. A 33-year-old female patient received ACAM2000 (lot number VV04003A), TYPHIM VI (lot number B1026), and BIOTHRAX (lot number FAV230) on 06 April 2011. Medical history included "Morphine, DEMEROL, PHENERGAN". On 02 May 2011, 6 days post-vaccination, the patient developed a "normal reaction" to the ACAM2000, in addition to chest wall pain about the pectoralis major muscle group as well as the axillary region with a single axillary node enlargement noted on exam. The chest pain was determined to be non-cardiac, as the patient was tender to palpation about the left axilla and pectoralis major of the left chest. The patient's smallpox lesion was swollen, but consistent with others which her physician had seen in the past. The patient did complain of significantly more discomfort at the lesion site, however. No diagnostic testing was ordered, as the physician felt that the events would resolve over time. She was seen in the emergency department, and subsequently recovered on an unspecified date.
Age: 33.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Myalgia
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422778. A 33-year-old female patient received ACAM2000 (lot number VV04003A), TYPHIM VI (lot number B1026), and BIOTHRAX (lot number FAV230) on 06 April 2011. Medical history included "Morphine, DEMEROL, PHENERGAN". On 02 May 2011, 6 days post-vaccination, the patient developed a "normal reaction" to the ACAM2000, in addition to chest wall pain about the pectoralis major muscle group as well as the axillary region with a single axillary node enlargement noted on exam. The chest pain was determined to be non-cardiac, as the patient was tender to palpation about the left axilla and pectoralis major of the left chest. The patient's smallpox lesion was swollen, but consistent with others which her physician had seen in the past. The patient did complain of significantly more discomfort at the lesion site, however. No diagnostic testing was ordered, as the physician felt that the events would resolve over time. She was seen in the emergency department, and subsequently recovered on an unspecified date.
Age: 33.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Axillary pain, Injection site discomfort, Injection site swelling, Lymph node pain, Lymphadenopathy
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422778. A 33-year-old female patient received ACAM2000 (lot number VV04003A), TYPHIM VI (lot number B1026), and BIOTHRAX (lot number FAV230) on 06 April 2011. Medical history included "Morphine, DEMEROL, PHENERGAN". On 02 May 2011, 6 days post-vaccination, the patient developed a "normal reaction" to the ACAM2000, in addition to chest wall pain about the pectoralis major muscle group as well as the axillary region with a single axillary node enlargement noted on exam. The chest pain was determined to be non-cardiac, as the patient was tender to palpation about the left axilla and pectoralis major of the left chest. The patient's smallpox lesion was swollen, but consistent with others which her physician had seen in the past. The patient did complain of significantly more discomfort at the lesion site, however. No diagnostic testing was ordered, as the physician felt that the events would resolve over time. She was seen in the emergency department, and subsequently recovered on an unspecified date.
Age: 33.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Musculoskeletal chest pain, Tenderness
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422778. A 33-year-old female patient received ACAM2000 (lot number VV04003A), TYPHIM VI (lot number B1026), and BIOTHRAX (lot number FAV230) on 06 April 2011. Medical history included "Morphine, DEMEROL, PHENERGAN". On 02 May 2011, 6 days post-vaccination, the patient developed a "normal reaction" to the ACAM2000, in addition to chest wall pain about the pectoralis major muscle group as well as the axillary region with a single axillary node enlargement noted on exam. The chest pain was determined to be non-cardiac, as the patient was tender to palpation about the left axilla and pectoralis major of the left chest. The patient's smallpox lesion was swollen, but consistent with others which her physician had seen in the past. The patient did complain of significantly more discomfort at the lesion site, however. No diagnostic testing was ordered, as the physician felt that the events would resolve over time. She was seen in the emergency department, and subsequently recovered on an unspecified date.
Age: 57.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dyspnoea, Dyspnoea exertional, Electrocardiogram ambulatory, Palpitations, Ventricular extrasystoles
Clinical narrative: This case was received on 21 July 2011 via third party query tool search on the VAERS database, under reference number 422804. A 57 year-old male patient with no current illnesses at the time of vaccination and a history of gastroparesis and arthritis had received a right arm injection of ACAM2000 (lot number not reported) on 13 April 2011 and five days later on 18 April 2011, experienced almost continuous palpitations and some shortness of breath with low level of exertion. He was evaluated by a cardiologist and was wearing a Holter monitor which revealed multiple PVC's. According to the report, cardiology considered them to be benign but the patient was scheduled for an US (ultrasound) to check for carditis. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Age: 57.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dyspnoea, Electrocardiogram ambulatory abnormal, Palpitations, Respiration abnormal, Ventricular extrasystoles
Clinical narrative: This case was received on 21 July 2011 via third party query tool search on the VAERS database, under reference number 422804. A 57 year-old male patient with no current illnesses at the time of vaccination and a history of gastroparesis and arthritis had received a right arm injection of ACAM2000 (lot number not reported) on 13 April 2011 and five days later on 18 April 2011, experienced almost continuous palpitations and some shortness of breath with low level of exertion. He was evaluated by a cardiologist and was wearing a Holter monitor which revealed multiple PVC's. According to the report, cardiology considered them to be benign but the patient was scheduled for an US (ultrasound) to check for carditis. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.